The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis
Open accessAbstract
Ischemic brain injury resulting from stroke arises from primary neuronal losses and by inflammatory responses. Previous studies suggest that erythropoietin (EPO) attenuates both processes. Although EPO is clearly antiapoptotic for neurons after experimental stroke, it is unknown whether EPO also directly modulates EPO receptor (EPO-R)–expressing glia, microglia, and other inflammatory cells. In these experiments, we show that recombinant human EPO (rhEPO; 5,000 U/kg body weight, i.p.) markedly reduces astrocyte activation and the recruitment of leukocytes and microglia into an infarction produced by middle cerebral artery occlusion in rats. In addition, ischemia-induced production of the proinflammatory cytokines tumor necrosis factor, interleukin 6, and monocyte chemoattractant protein 1 concentration is reduced by >50% after rhEPO administration. Similar results were also observed in mixed neuronal-glial cocultures exposed to the neuronal-selective toxin trimethyl tin. In contrast, rhEPO did not inhibit cytokine production by astrocyte cultures exposed to neuronal homogenates or modulate the response of human peripheral blood mononuclear cells, rat glial cells, or the brain to lipopolysaccharide. These findings suggest that rhEPO attenuates ischemia-induced inflammation by reducing neuronal death rather than by direct effects upon EPO-R–expressing inflammatory cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid colorimetric assay for cell growth and survival
Denizot, F., & Lang, R. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90368-6 · Cited by 4,935
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Self-citationErythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Self-citationPhagocyte recognition of cells undergoing apoptosis
Savill, J., Fadok, V., Henson, P., & Haslett, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90215-7 · Cited by 985
Digicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923
A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice
Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T., & Petit, E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00007 · Cited by 715
Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U., & Meisel, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10291.2002 · Cited by 462
Erythropoietin and Erythropoietin Receptor in the Developing Human Central Nervous System
Juul, S. E., Anderson, D. K., Li, Y., & Christensen, R. D. (1998) · Pediatric Research · doi:10.1203/00006450-199801000-00007 · Cited by 359
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain
Sirén, A.-L., Knerlich, F., Poser, W., Gleiter, C. H., Brück, W., & Ehrenreich, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010000297 · Cited by 349
The phosphatidylserine receptor: a crucial molecular switch?
Henson, P. M., Bratton, D. L., & Fadok, V. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085094 · Cited by 321
Nagai, A., Nakagawa, E., Choi, H. B., Hatori, K., Kobayashi, S., & Kim, S. U. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.386 · Cited by 306
Sugawa, M., Sakurai, Y., Ishikawa-Ieda, Y., Suzuki, H., & Asou, H. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00161-x · Cited by 197
Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia.
Meistrell, M. E., Botchkina, G. I., Wang, H., Santo, E. D., Cockroft, K. M., Bloom, O., Vishnubhakat, J. M., Ghezzi, P., & Tracey, K. J. (1997) · PubMed · Cited by 168
Self-citationGlia Increase Degeneration of Hippocampal Neurons through Release of Tumor Necrosis Factor-α
Viviani, B., Corsini, E., Galli, C. L., & Marinovich, M. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8406 · Cited by 128
Self-citationTargeting the central nervous system inflammatory response in ischemic stroke
Becker, K. J. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200106000-00014 · Cited by 76
Agnello, D., Carvelli, L., Muzio, V., Villa, P., Bottazzi, B., Polentarutti, N., Mennini, T., Mantovani, A., & Ghezzi, P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00279-4 · Cited by 52
Self-citationInterleukin‐1 and Tumor Necrosis Factor‐α Inhibit Erythropoietin Production in Vitroa
Fandrey, J., & JELKMANN, W. E. B. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb17252.x · Cited by 45
IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice
Santo, E. D., Meazza, C., Sironi, M., Fruscella, P., Mantovani, A., Sipe, J. D., & Ghezzi, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.379 · Cited by 43
Self-citationDHEAS Inhibits TNF Production in Monocytes, Astrocytes and Microglial Cells
Santo, E. D., Foddi, M. C., Ricciardi‐Castagnoli, P., Mennini, T., & Ghezzi, P. (1997) · NeuroImmunoModulation · doi:10.1159/000097282 · Cited by 43
Self-citationDying neural cells activate glia through the release of a protease product
Viviani, B., Corsini, E., Galli, C. L., Padovani, A., Ciusani, E., & Marinovich, M. (2000) · Glia · Cited by 41
Self-citationInhibition of erythropoietin production in vitro by human interferon gamma
Vannucchi, A. M., Grossi, A., Rafanelli, D., Statello, M., Cinotti, S., & Rossi-Ferrini, P. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04864.x · Cited by 40
Species-specific second antibodies reduce spurious staining in immunocytochemistry.
Houser, C. R., Barber, R. P., Crawford, G. D., Matthews, D. A., Phelps, P. E., Salvaterra, P. M., & Vaughn, J. E. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.4.6368679 · Cited by 38
Tabata, M., Tarumoto, T., Ohmine, K., Furukawa, Y., Hatake, K., Ozawa, K., Hasegawa, Y., Mukai, H. Y., Yamamoto, M. P., & Imagawa, S. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200002)186:2<260::aid-jcp1025>3.0.co;2-k · Cited by 31
Sacco, S., Agnello, D., Sottocorno, M., Lozza, G., Monopoli, A., Villa, P., & Ghezzi, P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052063.x · Cited by 29
Self-citationSystemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice
Santo, E. D., Adami, M., Bertorelli, R., & Ghezzi, P. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01225-9 · Cited by 27
Self-citationNitric oxide donors suppress erythropoietin production in vitro
Schobersberger, W., HOFFMANN, G. E., & Fandrey, J. (1996) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050225 · Cited by 27
Benigni, F., Villa, P., Demitri, M. T., Sacco, S., Sipe, J. D., Lagunowich, L. A., Panayotatos, N., & Ghezzi, P. (1995) · Molecular Medicine · doi:10.1007/bf03401594 · Cited by 27
Self-citation
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Robertson, C. S., Hannay, H. J., Yamal, J.-M., Gopinath, S., Goodman, J. C., Tilley, B. C., Baldwin, A., Rivera Lara, L., Saucedo-Crespo, H., Ahmed, O., et al. (2014) · JAMA · doi:10.1001/jama.2014.6490 · Cited by 525
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
Self-citationThe non‐haematopoietic biological effects of erythropoietin
Arcasoy, M. O. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07014.x · Cited by 347
Erythropoietin Improved Neurologic Outcomes in Newborns With Hypoxic-Ischemic Encephalopathy
Zhu, C., Kang, W., Xu, F., Cheng, X., Zhang, Z., Jia, L., Ji, L., Guo, X., Xiong, H., Simbruner, G., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-3553 · Cited by 354
Metadata
- Authors
- Villa, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., Viviani, B., Marinovich, M., Cerami, A., Coleman, T. R., Brines, M., & Ghezzi, P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-09-15
- Volume
- 198
- Issue
- 6
- Pages
- 971-975
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2108089603
- Cited by
- 527
- References
- 27
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.